| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 90,600 | -179,500 | -145,700 | -313,200 | 490,400 |
| Sales Growth | +150.47% | -23.20% | +53.48% | -163.87% | +124.54% |
| Net Income | 66,900 | -205,600 | -171,300 | -341,500 | 449,300 |
| Net Income Growth | +132.54% | -20.02% | +49.84% | -176.01% | +142.34% |
Ip Group Plc (IPO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
IP Group PLC is an early-stage science investor supporting businesses in deeptech, life sciences, and cleantech. It helps develop intellectual property-based companies through partnerships with research universities. The group provides its portfolio companies with financial capital from outside sources or its resources. IP Group also provides companies with guidance and mentorship. The group operates in the following segments: Venture Capital investing in Healthier Future thematic area, Venture Capital investing in Tech-enriched Future thematic area, Venture Capital investing in Regenerative Future thematic area, Venture Capital investing in others, and the management of third-party funds and the provision of corporate finance advice.
Fiscal Year End Date: 12/31